Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A LeBlanc

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Virology|September 18, 1999
Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivationR A LeBlanc, L Pesnicak, M Godleski, et al.
The Journal of Infectious Diseases|August 7, 1999
The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in miceR A LeBlanc, L Pesnicak, M Godleski, et al.
The Journal of General Virology|September 1, 1995
Defective entry of herpes simplex virus types 1 and 2 into porcine cells and lack of infection in infant pigs indicate species tropismG Subramanian, R A LeBlanc, R C Wardley, et al.
Journal of Virology|September 11, 1999
Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout miceR A LeBlanc, L Pesnicak, E S Cabral, et al.
The American Journal of Cardiology|September 1, 1988
Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillationM Shenasa, T Kus, M Fromer, et al.
Journal of Virology|June 23, 2000
Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in miceJ A Lekstrom-Himes, R A LeBlanc, L Pesnicak, et al.
The American Journal of Cardiology|February 1, 1987
Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndromeM Shenasa, M Fromer, G Faugere, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Virology|September 18, 1999
Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivationR A LeBlanc, L Pesnicak, M Godleski, et al.
The Journal of Infectious Diseases|August 7, 1999
The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in miceR A LeBlanc, L Pesnicak, M Godleski, et al.
The Journal of General Virology|September 1, 1995
Defective entry of herpes simplex virus types 1 and 2 into porcine cells and lack of infection in infant pigs indicate species tropismG Subramanian, R A LeBlanc, R C Wardley, et al.
Journal of Virology|September 11, 1999
Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout miceR A LeBlanc, L Pesnicak, E S Cabral, et al.
The American Journal of Cardiology|September 1, 1988
Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillationM Shenasa, T Kus, M Fromer, et al.
Journal of Virology|June 23, 2000
Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in miceJ A Lekstrom-Himes, R A LeBlanc, L Pesnicak, et al.
The American Journal of Cardiology|February 1, 1987
Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndromeM Shenasa, M Fromer, G Faugere, et al.
Pageof 1